Pharmacielo - Stock

Pharmacielo ROA 2024

Pharmacielo ROA

-0.58

Ticker

PCLO.V

ISIN

CA71716K1012

WKN

A2PCAX

In 2024, Pharmacielo's return on assets (ROA) was -0.58, a -21.96% increase from the -0.74 ROA in the previous year.

Pharmacielo Aktienanalyse

What does Pharmacielo do?

Pharmacielo Ltd is a company specializing in the production of medical cannabis products. The company is based in Canada, but its production facilities are located in Colombia, one of the most important cultivation areas for cannabis worldwide. The company was founded in 2014 by individuals with experience in commercial cultivation of crops. Its goal is to establish a safe and efficient production of medical cannabis in Colombia to ensure high-quality and affordable supply for patients worldwide. Pharmacielo Ltd's business model is based on the production and delivery of medical cannabis products to customers worldwide. The company produces cannabis flowers, extracts, and oils that are used to treat various medical conditions such as cancer, chronic pain, and neurological disorders. Pharmacielo Ltd works closely with the Colombian government to regulate and standardize the cultivation of medical cannabis to ensure high quality and purity of its products. The company has already received various certifications and approvals confirming the quality and safety of its products. Pharmacielo Ltd is divided into different divisions specializing in production and logistics. The "Production" division is responsible for the cultivation and harvesting of cannabis. Pharmacielo Ltd collaborates with various partners to ensure a large production capacity. The "Extraction" division is responsible for the production of medical cannabis extracts and oils. The dried cannabis flowers are dissolved in a liquid and then extracted to isolate the desired components. The "Logistics" division is responsible for the delivery of products to customers worldwide. The company works with various shipping service providers to ensure fast and reliable delivery of its products. Pharmacielo Ltd offers a wide range of products made from medical cannabis, including cannabis flowers in different varieties and sizes that can be selected based on individual needs. Additionally, products such as oils, extracts, and capsules are offered, which have a higher concentration of cannabinoids and are therefore particularly suitable for the treatment of serious illnesses such as cancer or epilepsy. Overall, Pharmacielo Ltd has become a leading company in the production and delivery of medical cannabis in recent years. The company works closely with the government and other companies to ensure a safe and reliable supply for patients worldwide. With its wide range of products and innovative production technology, Pharmacielo Ltd is well positioned to continue growing and meeting the needs of customers in the future. Pharmacielo ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Pharmacielo's Return on Assets (ROA)

Pharmacielo's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Pharmacielo's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Pharmacielo's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Pharmacielo’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Pharmacielo Stock

What is the Return on Assets (ROA) of Pharmacielo this year?

The Return on Assets (ROA) of Pharmacielo is -0.58 undefined this year.

What was the ROA of Pharmacielo compared to the previous year?

The ROA of Pharmacielo has increased by -21.96% compared to the previous year.

What consequences do high ROA have for investors of Pharmacielo?

A high ROA is advantageous for investors of Pharmacielo, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Pharmacielo?

A low ROA can be unfavorable for investors of Pharmacielo as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Pharmacielo affect the company?

An increase in ROA of Pharmacielo can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Pharmacielo impact the company?

A reduction in the ROA of Pharmacielo can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Pharmacielo?

Some factors that can influence the ROA of Pharmacielo include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Pharmacielo important for investors?

The ROA of Pharmacielo is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Pharmacielo take to improve ROA?

To improve ROA, Pharmacielo can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Pharmacielo pay?

Over the past 12 months, Pharmacielo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pharmacielo is expected to pay a dividend of 0 CAD.

What is the dividend yield of Pharmacielo?

The current dividend yield of Pharmacielo is .

When does Pharmacielo pay dividends?

Pharmacielo pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pharmacielo?

Pharmacielo paid dividends every year for the past 0 years.

What is the dividend of Pharmacielo?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pharmacielo located?

Pharmacielo is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharmacielo kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharmacielo from 6/21/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 6/21/2024.

When did Pharmacielo pay the last dividend?

The last dividend was paid out on 6/21/2024.

What was the dividend of Pharmacielo in the year 2023?

In the year 2023, Pharmacielo distributed 0 CAD as dividends.

In which currency does Pharmacielo pay out the dividend?

The dividends of Pharmacielo are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pharmacielo

Our stock analysis for Pharmacielo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharmacielo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.